Documentos de Pandian J.D. | REDI

Regresar

Mostrando 3 resultados de: 3

Filtros aplicados

Área temáticas: "Ginecología, obstetricia, pediatría, geriatría"

Subtipo de publicación

Conference Object(1)

Publisher

JAMA Neurology(1)

Área temáticas

Enfermedades(3)

Medicina y salud(2)

Fisiología humana(1)

Área de conocimiento

Medicina interna(3)

Año de Publicación

Origen

Palabras Claves

Hypertension(2)

Blood pressure(1)

Brain Infarction(1)

Ischemic stroke(1)

Tissue plasminogen activator(1)

Associations of Early Systolic Blood Pressure Control and Outcome after Thrombolysis-Eligible Acute Ischemic Stroke: Results from the ENCHANTED Study

Abstract: Background and Purpose: In thrombolysis-eligible patients with acute ischemic stroke, there is uncer

Palabras claves:

Blood pressure, Hypertension, intracranial hemorrhage, Ischemic stroke

Anderson C.S., Arima H., Bath P.M.W., Broderick J.P., Chalmers J., Chen G., Chen X., Delcourt C., Demchuk A.M., Donnan G.A., Durham A.C., Lavados P.M., Lee T.H., Levi C., Lindley R.I., Luca Di Tanna G., Martins S.O., Minhas J.S., Moullaali T.J., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Parsons M.W., Ricci S., Robinson T.G., Sato S., Sharma V.K., Silva-Sieger F.A., Song L., Thang N.H., Wang J.G., Wang X., Woodward M.

Low-Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy the ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study)

Conference Object

Abstract: Background and Purpose'Many patients receiving thrombolysis for acute ischemic stroke are on prior a

Palabras claves:

aspirin, Brain Infarction, Hypertension, intracranial hemorrhages, Tissue plasminogen activator

Arima H., Bath P.M.W., Billot L., Broderick J.P., Chalmers J., Demchuk A.M., Donnan G.A., Kim J.S., Lavados P.M., Lee T.H., Lindley R.I., Martins S.O., Nguyen T.H., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Parsons M.W., Ricci S., Robinson T.G., S Anderson C., Sato S., Sharma V.K., Wang J.G., Wang X., Woodward M.

Low-dose vs standard-dose alteplase for patients with acute ischemic stroke: Secondary analysis of the ENCHANTED randomized clinical trial

Abstract: IMPORTANCE: A lower dose of intravenous alteplase appears to be a safer treatment option than the st

Palabras claves:

Arima H., Bath P.M.W., Billot L., Broderick J.P., Chalmers J., Demchuk A.M., Donnan G.A., Kim J.S., Lavados P.M., Lee T.H., Li Q., Lindley R.I., Martins S.O., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Parsons M.W., Ricci S., Robinson T.G., S Anderson C., Sharma V.K., Thang N.H., Wang J.G., Wang X., Woodward M.